Vertex Pharmaceuticals Incorporated

11/20/2019 | Press release | Distributed by Public on 11/20/2019 04:01

French Authorities Approve National Reimbursement of ORKAMBI (lumacaftor/ivacaftor) for Eligible People Ages Two and Older With Cystic Fibrosis